Wafik S El-Deiry, Director of the Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared some top articles.
1. Title: Nanobioreactor detection of space-associated hematopoietic stem and progenitor cell aging
Journal: The Cell
Authors: Jessica Pham, Jane Isquith, Larisa Balaian, Shuvro P. Nandi, Claire Engstrom, Karla Mack, Inge van der Werf, Patrick Chang, Jana Stoudemire, Luisa Ladel, Emma Klacking, Antonio Ruiz, Daisy Chilin-Fuentes, Jenna Sneifer, David Mays, Paul Gamble, Shelby Giza, Jiya Janowitz, Trevor Nienaber, Tejaswini Mishra, Anna A. Khachatrian, Elsa Molina, Michael P. Snyder, Sheldon R. Morris, Twyman Clements, Alysson R. Muotri, Thomas Whisenant, Ludmil B. Alexandrov, Catriona H.M. Jamieson
2. Title: Past, present and future of drug conjugates for cancer therapy
Journal: Nature Cancer
Authors: S. Cazzamalli, E. Puca, D. Neri
3. Title: Computational pathology annotation enhances the resolution and interpretation of breast cancer spatial transcriptomics data
Journal: npj Precision Oncology
Authors: Tianyi Li, Qiao Yang, Balazs Acs, Emmanouil G. Sifakis, Hosein Toosi, Camilla Engblom, Kim Thrane, Qirong Lin, Jeff E. Mold, Wenwen Sun, Ceren Boyaci, Sanna Steen, Jonas Frisén, Jens Lagergren, Joakim Lundeberg, Xinsong Chen, Johan Hartman
4. Title: Antibody–bottlebrush prodrug conjugates for targeted cancer therapy
Journal: Nature Biotechnology
Authors: Bin Liu, Hung V.-T. Nguyen, Yivan Jiang, Aiden X. Wang, Valerie Lensch, Zehao Sun, Zane H. Boyer, Philip A. Raftopoulos, Yutong Dai, Piper L. MacNicol, Yuyan Wang, Nidhi Jyotsana, Wencong Wang, Sachin Bhagchandani, Sanjana Hemdev, Peyton Shieh, Samantha L. Kristufek, Magalie Boucher, Michael Downes, Ronald M. Evans, David W. C. MacMillan, Jeremiah A. Johnson
5. Title: The multi-kingdom cancer microbiome
Journal: Nature Microbiology
Authors: Anders B. Dohlman, Xiangyu Pan, Laurence Zitvogel, Iliyan D. Iliev
6.“At 42 months median follow-up, 3-year RFS for HCQ, EVE & HCQ + EVE was 91.7%, 92.9% & 100%, respectively, and was > in those who cleared DTCs vs those who did not”
Title: Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial
Journal: Nature Medicine
Authors: Angela DeMichele, Amy S. Clark, Emily Shea, Lauren J. Bayne, Christopher J. Sterner, Killian Rohn, Samantha Dwyer, Tien-chi Pan, Isoris Nivar, Yan Chen, Paul Wileyto, Lindsay R. Berry, Shannon Deluca, Jessica Savage, Igor Makhlin, Dhruv K. Pant, Heather Martin, Adetutu Egunsola, Nathan Mears, Brooke L. Goodspeed, Elizabeth M. Chislock, Jewell Graves, Jianping Wang, Natalie Shih, George K. Belka, Don Berry, Anupma Nayak, Michael Feldman & Lewis A. Chodosh
More from Wafik El-Deiry on OncoDaily.